Concepedia

Michael Wendt

MW

Statistics

Publications

130

Citations

12.3K

H-Index

42

Active since

1976

Affiliations

Universität Greifswald(Current)

University of Veterinary Medicine Hannover, Foundation

Abbott Fund

Universitätsmedizin Greifswald

V. Bakul Institute for Superhard Materials

Michael Wendt is an author at Universität Greifswald specializing in medicine, pharmacology, and natural sciences.

ORCID

Publications per year

1976–2024

130

Publications

130

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Tilman Oltersdorf, Steven W. Elmore, Alexander R. Shoemaker et al. · Nature · 2005 · 3.4K citations

, , +14

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Andrew J. Souers, Joel D. Leverson, Erwin R. Boghaert et al. · Nature Medicine · 2013 · 3K citations

, , +10

Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy

Joel D. Leverson, Darren C. Phillips, Michael J. Mitten et al. · Science Translational Medicine · 2015 · 541 citations · Full text

, , +14

Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL

Milan Bruncko, Thorsten Oost, Barbara Belli et al. · Journal of Medicinal Chemistry · 2007 · 295 citations · Full text

, , +14

Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins

Cheol‐Min Park, Milan Bruncko, Jessica Adickes et al. · Journal of Medicinal Chemistry · 2008 · 293 citations · Full text

, , +16

1–5 of 130